Combined first-trimester versus second-trimester serum screening for Down syndrome: A cost analysis

This publication has 19 references indexed in Scilit:

• Screening for Down's syndrome: effects, safety, and cost effectiveness of first and second trimester strategies Commentary: Results may not be widely applicable Authors' response
  BMJ, 2001
• Efficacy of screening for fetal down syndrome in the United States from 1974 to 1997
  Obstetrics & Gynecology, 2000
• One stop clinic for assessment of risk for fetal anomalies: a report of the first year of prospective screening for chromosomal anomalies in the first trimester
  BJOG: An International Journal of Obstetrics and Gynaecology, 2000
• First-Trimester down syndrome screening using dried blood biochemistry and nuchal translucency
  Obstetrics & Gynecology, 2000
• Cost-benefit analysis of prenatal diagnosis for down syndrome using the British or the American approach
  Obstetrics & Gynecology, 2000
• Fetal Down syndrome screening: A cost effectiveness analysis of alternative screening programs
  The Journal of Maternal-Fetal Medicine, 1999
• Maternal age‐ and gestation‐specific risk for trisomy 21
  Ultrasound in Obstetrics & Gynecology, 1999
• Economic evaluation of prenatal screening for Down syndrome in the U.S.A.
  Prenatal Diagnosis, 1998
• The imprecision in rates of down syndrome by 1‐year maternal age intervals: A critical analysis of rates used in biochemical screening
  Prenatal Diagnosis, 1994
• Prenatal Screening for Down's Syndrome with Use of Maternal Serum Markers
  New England Journal of Medicine, 1992